The poor and vulnerable beneficiaries of PM JAY have been from both urban and rural locations in India. Pooja Thapa, the one crore th beneficiary, a housewife with two small children, and a husband serving in the army, is from Meghalaya, and she got her treatment in a Shillong hospital. During her interactions with PM Modi, she thanked him and said that she underwent free surgery including free medicines, and is on the road to recovery.PM JAY is a giant step towards a healthy India, as it aims to make affordable, accessible healthcare a reality for all. PM JAY has crossed a significant milestone of one crore hospitalisations, worth over Rs. 13,412 crore, in less than 20 months since its launch on September 23, 2018. Delivering one crore free and cashless treatments in this time period shows that there was a lot of demand and people needed a scheme like PM JAY. The efforts of the doctors, nurses, healthcare workers, para medical staff and all others associated with Ayushman Bharat, across all states, have helped in making it the largest healthcare programme in the world.
FB Twitter ellipsis More Pinterest Mail Email iphone Send Text Message Print A Florida judge ruled against a four year old #x2019;s parents Monday, ordering the child to stay with his maternal grandparents after the parents stopped their son #x2019;s chemotherapy treatments, a public information officer for the court confirmed to PEOPLE.Noah McAdams was diagnosed with leukemia in April and started chemotherapy at Johns Hopkins All Children #x2019;s Hospital in St. Petersburg, Florida. But his parents, Joshua McAdams and Taylor Bland Ball, said that the treatment made Noah violent and gave him mood swings, and eventually wanted to seek a second opinion about natural treatment options, stopping the chemotherapy.
Researchers at the City of Hope s Translational Genomics Research Institute, the Mayo Clinic in Arizona and the Cancer Research UK Cambridge Institute hope the liquid biopsy test could potentially assist oncologists in better assigning targeted treatments, as well as help some patients avoid unnecessary surgeries.The technique dubbed TARgeted DIgital Sequencing, or TARDIS starts with a traditional tissue biopsy of excised tumor cells, which are sequenced and analyzed to identify the founding mutations that would be present in every one of the patient s cancer cells. The test then matches those personalized DNA sequences to the fragments of genetic material released by tumors into the bloodstream.
In a press briefing Thursday, PhilHealth said it filed administrative cases against WellMed Dialysis and Laboratory Center in Novaliches, Quezon City last November for misrepresentation and falsification. At least four doctors also face complaints for possible involvement in the scheme. ”This is the truth of it that we acted upon this case and not sitting on it, ” Roy Ferrer, acting president and CEO of PhilHealth, said.
Rheumatoid Arthritis (RA) Market report covers the disease overview, definition, classification, symptoms, ethology, pathophysiology and diagnostic methods. The investigation depends on patient take up by treatments, deals forecast of each medication by concentrate the explanations for the maximal utilization of new medicines. A relative investigation is likewise done based on part of the overall industry and size by evaluating the drugs take up to extend the treatment situating in the market. It also covers the complete treatment methodologies and therapy areas under research and development
The researchers describe their study and results in the European Journal of Preventive Cardiology, in a paper titled, Parental smoking and the risk of congenital heart defects in offspring: An updated meta analysis of observational studies. Congenital heart defects affect approximately 8% of live births worldwide, and are a leading cause of death in newborns, the authors wrote. Prognosis and quality of life are improving thanks to innovative treatments, including surgeries, but the effects on affected children are nevertheless lifelong. Smoking is known to pose a risk to normal fetal development, Qin noted, and there is increasing interest in the potential link between parental smoking and heart defects in their offspring. "Smoking is teratogenic, meaning it can cause developmental malformations, Qin said. The association between prospective parents smoking and the risk of congenital heart defects has attracted more and more attention with the increasing number of smokers of childbearing age. "
RegisterSUDBURY The computer virus that is impacting operations at Health Sciences North this week has forced the cancellation of numerous clinics and treatments, delays in various departments and the rescheduling of some procedures.
This is why Nalinikanth Kotagiri, MD, Ph.D., assistant professor in the James L. Winkle College of Pharmacy and a cluster hire for the Cincinnati Cancer Center, is hoping to study ways ultraviolet light can activate light sensitive drugs to treat this invasive breast cancer and provide that light at the end of the tunnel patients yearn for."Metastatic breast cancer can be a devastating diagnosis with high rates of relapse and death, and there are currently no effective therapies," he says. "Despite newer treatments, many patients still succumb to the disease. Major limitations include acquired resistance to therapies and serious side effects from treatment. Due to the widespread location of breast cancer cells, particularly in the bone marrow, which harbors the tumor cells as well as vital stem cells, the risk of toxicity is even higher with conventional therapies. Therefore, new therapeutic strategies that selectively destroy tumor cells, increase treatment efficacy, prevent relapse and reduce side effects by sparing the healthy stem cells are necessary."
It turns out we #x27;ll be able to serve well over 99 percent of the queries, that users request. What s more, There are many, many areas where we would provide information better than what #x27;s available, such as searching for cancer treatments, Pichai said. quot;Today people either get fake cancer treatments or they actually get useful information.
Inhibiting a previously known protein could reduce tumour burden and enhance the effectiveness of immunotherapy treatments, a study has found.
The short answer is that, for the majority of Ebola s known existence, governments and pharmaceutical companies didn t allocate the sort of resources needed to find and develop treatments, both for practical and economical reasons. But following the major outbreak of Ebola in 2014, that trend is changing.Sufferers of Ebola initially develop a flu like illness. Oftentimes, though, the virus tears through the immune system with ease, causing it to spiral out of control and attack the body in a desperate bid to kill the virus. Ebola also infects the cells that line our blood vessels and organs, hampering their ability to properly clot, which helps trigger the telltale widespread hemorrhaging.
Chicago researchers are spearheading efforts to find the complex biological underpinnings of autism a brain disorder that affects one in 68 American children.The work, aimed at developing drugs and other targeted, personalized treatments, is underway at the same time as World Autism Month (April) boosts awareness of the challenges faced by people on the autism spectrum.
A collection of homeopathic treatments, including preparations made with robinia, castor bean, silver phosphate, and clippings of Wintergreen and rosemary. (AP Josh Reynolds)
quot;Bariatric surgery is the most effective option for obesity and its complications, such as type 2 diabetes, quot; said Margaret A. Stefater, M.D, Ph.D., the lead author of the study and a fellow at Boston Children #39;s Hospital, Harvard Medical School in Boston, Mass. In many people who have had RYGB, their diabetes abates even before they start to lose weight. However, quot;bariatric surgery is not for everyone with obesity, as it is associated with side effects. Our aim is to #39;reverse engineer #39; the surgery, to find how it works and apply the mechanisms to new, less invasive treatments, quot; Stefater said.Stefater is spearheading a study investigating whether changes in the intestine of human patients who undergo the surgery could lead to weight loss and diabetes improvement. This is an NIH funded registered clinical trial, which is a collaboration between Dr. Nicholas Stylopoulos of Boston Children #39;s Hospital and Dr. Anita Courcoulas of the University of Pittsburgh. A total of 32 patients will be recruited for this study; the data presented at the meeting is based on the first 19 patients. The researchers obtained intestinal biopsies of the patients in the study at the time of the surgery, and 1, 6 and 12 months afterwards. They performed analysis of the samples to look for changes in the expression of genes over time.
The two conditions were chosen as part of the department's regular review of requests to expand the use of medical cannabis. Petitioners sought authority for 10 conditions this year, including anxiety disorders, dementia, liver disease, Parkinson's disease, apnea and autism.State health officials backed cannabis for autism after their review found a "lack of effective drug treatments, the potentially severe side effects of current drug treatments and anecdotal evidence of Minnesota children with autism already receiving benefits from medical cannabis taken for other qualifying conditions," the Health Department said in a statement.
The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson s Research (MJFF), found that people with Parkinson s who injected themselves each week with exenatide for one year performed better in movement (motor) tests than those who injected a placebo.Also read: more news stories from the Michael J. Fox Foundation This is a very promising finding, as the drug holds potential to affect the course of the disease itself, and not merely the symptoms, said the study s senior author, Professor Tom Foltynie (UCL Institute of Neurology). With existing treatments, we can relieve most of the symptoms for some years, but the disease continues to worsen. The researchers followed 60 people with Parkinson s disease at the National Hospital for Neurology and Neurosurgery (NHNN) as they used either a once weekly injection of exenatide for 48 weeks, or a placebo, in addition to their regular medications.They found that people who used exenatide had better motor function at 48 weeks when they came off the treatment, which persisted after the 12 week follow up. Those who had injected the placebo showed a decline in their motor scores at both the 48 and 60 week tests. The advantage of 4 points, on a 132 point scale of measures such as tremors, agility and speech, was statistically significant.The participants did not report noticeable improvements in their symptoms during the trial period beyond what their standard medication already did for them. They were tested while temporarily off all medication, to determine how the disease itself was progressing. The research did not determine conclusively whether the drug was modifying the disease itself, so the next stage in the research will investigate that more fully.Parkinson s disease affects 1 in 500 people and is the second most common neurodegenerative disease worldwide. Symptoms typically don t become apparent until over 70% of the brain s dopamine producing cells have been affected. The condition results in muscle stiffness, slowness of movement, tremors, sleep disturbance, chronic fatigue and an impaired quality of life.Learn more: Parkinson's Disease researchThe saliva of the Gila monster lizard provided the inspiration for the development of exenatide, which has been used since 2005 to treat Type 2 diabetes. It activates receptors for the GLP 1 hormone in the pancreas to stimulate insulin release. GLP 1 receptors are also found in the brain, and prior research has shown that activating them can boost the function of dopamine connections, act as an anti inflammatory, improve energy production, and switch on cell survival signals. Further research by a team led by Professor Foltynie will seek to clarify how exenatide works for people with Parkinson s disease.Prior evidence in animal models demonstrated that exenatide improved motor performance. Another study also found early evidence that it could be a disease modifying agent for Parkinson s, but it was an open label trial, so this latest study strengthens the existing evidence as the first randomised, placebo controlled trial of the drug for Parkinson s patients. This is the strongest evidence we have so far that a drug could do more than provide symptom relief for Parkinson s disease, said Professor Foltynie. Using approved therapies for one condition to treat another, or drug repurposing, offers new avenues to speed Parkinson s therapeutic development, said Dr Brian Fiske, senior vice president of research programs at MJFF. The results from the exenatide studies justify continued testing, but clinicians and patients are urged not to add exenatide to their regimens until more is known about their safety and impact on Parkinson s. While we are optimistic about the results of our trial, there is more investigation to be done, and it will be a number of years before a new treatment could be approved and ready for use. We also hope to learn why exenatide appears to work better for some patients than for others, said the study s first author, Dr Dilan Athauda (UCL Institute of Neurology).This article has been republished from materials provided by UCL. Note: material may have been edited for length and content. For further information, please contact the cited source. A Blood based Screening Test for Alzheimer's
Newscasts amp; VideosWATCH: Moaza Al Matrooshi went from having a potentially fatal blood disorder, to chemo treatments, experiencing premature menopause then later giving birth thanks to fertility preservation.
(PRLEAP.COM) August 31, 2016 Apart from offering SMP treatments, it also provides SMP training programs to the enthusiasts who dream of establishing themselves as experts in this promising industry. SMC is the most advanced SMP training clinic in the world specializing in hair tattoo, scalp tattoo, SMP hair density and SMP Scalp Camouflage treatments. SMP is a perfect solution that involves the use of micro needles to add color to the inner skin of the scalp that replicates hair follicles. This gives a 'buzz cut; or recently shaven look to the otherwise bald head. Men happily sport this fashion as it gives them a cover up for their bald heads in style, thereby, adding the extra zing to their personality. With SMC, people who are facing hair loss problems or want to be a part of this professional industry can get appropriate solutions for their problems.SMP Scalp Hair Tattoo Training Programs